Last week, consulting firm McKinsey & Company agreed to pay nearly $600 million for its role in the opioid crisis, after it allegedly tried to turbocharge sales of the highly addictive painkiller OxyContin in the U.S. and Canada. We talk to New York Times reporter Mike Forsythe about the landmark settlement.